Patent · US Active

Modified gapmer oligonucleotides and methods of use

US11466274B2 · kind B2 · utility

0Cited by
13References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 29, 2020
Grant dateOct 11, 2022
Priority date—
Expiry dateMay 29, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/32
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The disclosure includes antisense oligonucleotides, including gapmer antisense oligonucleotides, along with methods of making and use, e.g., against HBV.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.